Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Kaposi's sarcoma mimicking cellulitis

R L Oehler1, J T Sinnott, G Arepally

  • 1Emory University School of Medicine, Atlanta.

Postgraduate Medicine
|December 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The HIT Expert Probability (HEP) Score: a novel pre-test probability model for heparin-induced thrombocytopenia based on broad expert opinion.

Journal of thrombosis and haemostasis : JTH·2010
Same author

Platelet and monocyte antigenic complexes in the pathogenesis of heparin-induced thrombocytopenia (HIT).

Journal of thrombosis and haemostasis : JTH·2009
Same author

Antidote-controlled platelet inhibition targeting von Willebrand factor with aptamers.

Oligonucleotides·2007
Same author

Heparin-induced thrombocytopenia: bovine versus porcine heparin in cardiopulmonary bypass surgery.

The Annals of thoracic surgery·2001
Same author

Exposure of medical students to body fluids.

Journal of American college health : J of ACH·1999
Same author

A mouse model for heparin-induced thrombocytopenia.

Seminars in hematology·1999
Same journal

CV risk: if you aren't testing ACR, you aren't seeing the full picture.

Postgraduate medicine·2026
Same journal

Anti-TNF-induced vasculitis: analysis of data from the French national pharmacovigilance database.

Postgraduate medicine·2026
Same journal

Relationship of serum nesfatin-1 levels with body mass index and c-reactive protein in patients presenting to the emergency department with epileptic seizures.

Postgraduate medicine·2026
Same journal

Clinical pharmacokinetics of colistimethate sodium and formed colistin in patients with renal impairment or on dialysis modalities: a systematic review and implications for precision dosing.

Postgraduate medicine·2026
Same journal

The role of type D personality in pregnancy symptom severity, functional limitations, and maternal ambivalence.

Postgraduate medicine·2026
Same journal

Operational and demographic predictors of leaving without being seen in a high-volume tertiary emergency department: a five-year case-control study.

Postgraduate medicine·2026
See all related articles

Kaposi's sarcoma is an early opportunistic illness in AIDS patients, often presenting as leg swelling that mimics cellulitis. Treatment focuses on local effects unless the disease is widespread.

Area of Science:

  • Oncology
  • Infectious Diseases
  • Dermatology

Background:

  • Kaposi's sarcoma (KS) is an opportunistic illness frequently associated with human immunodeficiency virus (HIV) infection.
  • While not the leading cause of mortality in acquired immunodeficiency syndrome (AIDS) patients, KS often serves as an initial indicator of HIV infection.

Observation:

  • Extensive plaque formation and edema in the lower extremities can clinically resemble cellulitis.
  • In individuals with darker skin tones, the characteristic lesions of Kaposi's sarcoma may be less apparent or easily missed.

Findings:

  • The presentation of Kaposi's sarcoma can be variable, particularly in its early stages or in certain populations.
  • Diagnostic challenges arise due to its potential to mimic other conditions like cellulitis and its variable visibility.

Related Experiment Videos

Implications:

  • Early recognition of Kaposi's sarcoma, despite potential diagnostic challenges, is crucial for timely management of HIV-associated opportunistic illnesses.
  • Treatment strategies for Kaposi's sarcoma are primarily palliative, focusing on local therapies unless systemic involvement or extensive disease is present.